🔬 Archon's Antibody Cage Breakthrough

Archon Biosciences, a biotech startup, has unveiled its new "antibody cages" technology after raising $20 million in funding. This innovation aims to speed up drug development and make treatments more effective.

AI-driven antibody design is changing how we create therapeutic antibodies. Using machine learning, researchers can quickly analyze large amounts of data to predict how antibodies will behave and design new ones for specific targets.

Read More